These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Create or strengthen the drug committee at a hospital]. Bruneton C Med Trop (Mars); 2006 Dec; 66(6):569-72. PubMed ID: 17286023 [TBL] [Abstract][Full Text] [Related]
3. Health care and institutional pharmacy practice in Japan. Tsubaki T; Iga T; Chandler MH Am J Hosp Pharm; 1994 Feb; 51(4):535-8. PubMed ID: 8017427 [No Abstract] [Full Text] [Related]
4. Assuring the quality of a clinical pharmacokinetics service. Waller DJ; Smith SR Am J Hosp Pharm; 1986 Sep; 43(9):2184-8. PubMed ID: 3766569 [TBL] [Abstract][Full Text] [Related]
5. [Safer drug handling in hospitals. A new task for the drug committee]. Osterman PO; Gyllenspetz L; Hartvig P; Levol R; Rane A; Söderström A Lakartidningen; 1996 Oct; 93(44):3917-20. PubMed ID: 8965581 [No Abstract] [Full Text] [Related]
6. Some research opportunities in hospital pharmacy. Wertheimer AI Am J Hosp Pharm; 1981 Oct; 38(10):1534-6. PubMed ID: 7294056 [TBL] [Abstract][Full Text] [Related]
7. Managing the hospital pharmacy. Interview by Nancy M. Agresta. Lantos RL Hosp Formul; 1979 Sep; 14(9):839-43. PubMed ID: 10243910 [No Abstract] [Full Text] [Related]
8. Outcome-focused counseling program for quality assurance in ambulatory care. Koecheler JA; Sfeir TL; Wilson B Am J Hosp Pharm; 1990 Sep; 47(9):2020-2. PubMed ID: 2220854 [TBL] [Abstract][Full Text] [Related]
9. [Drug committee--an example of a quality circle]. Hammershøy E; Christensen U; Christensen I Ugeskr Laeger; 1991 Aug; 153(34):2330-3. PubMed ID: 1897040 [TBL] [Abstract][Full Text] [Related]
10. The Pharmacy and Therapeutics Committee Part 1: overview. Bender FH Hosp Formul; 1983 May; 18(5):517-8, 523-4, 533 passim. PubMed ID: 10260199 [TBL] [Abstract][Full Text] [Related]
11. Development and implementation of a comprehensive, criteria-based drug-use review program. Todd MW; Keith TD; Foster MT Am J Hosp Pharm; 1987 Mar; 44(3):529-35. PubMed ID: 3471089 [TBL] [Abstract][Full Text] [Related]
13. Design and implementation of a quality-assurance program for pharmaceutical services. Horowitz KN; Lamnin M Am J Hosp Pharm; 1980 Jan; 37(1):82-4. PubMed ID: 7361777 [TBL] [Abstract][Full Text] [Related]
14. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions. Hayman JN; Sbravati EC Am J Hosp Pharm; 1985 Jun; 42(6):1343-7. PubMed ID: 4014250 [TBL] [Abstract][Full Text] [Related]
15. Improving pharmacy and therapeutics committee operations. Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511 [TBL] [Abstract][Full Text] [Related]
17. We tried that and the medical staff said no. Holzman MS Hosp Pharm; 1989 Apr; 24(4):304, 306. PubMed ID: 10303545 [No Abstract] [Full Text] [Related]
18. P & T Committee interview: Establishing and maintaining a dynamic formulary. Rostand S; Lazarus H Hosp Formul; 1988 Jan; 23(1):48-53. PubMed ID: 10285373 [TBL] [Abstract][Full Text] [Related]
19. Improving quality of drug use through hospital directorates. Barber N Qual Health Care; 1993 Mar; 2(1):3-4. PubMed ID: 10132075 [No Abstract] [Full Text] [Related]
20. Implementing and maintaining a viable formulary. Kelly WN; Bender FH Hosp Formul; 1983 Oct; 18(10):976-8, 981-2, 987. PubMed ID: 10262828 [No Abstract] [Full Text] [Related] [Next] [New Search]